Showing 561-570 of 2320 results for "".
Novel Approaches to Nonmelanoma Skin Cancer
https://practicaldermatology.com/topics/skin-cancer-photoprotection/novel-approaches-to-nonmelanoma-skin-cancer/23696/New and emerging treatment options are advancing care for patients with NMSC.Five strategies to make the most of prejuvenation-minded dermatology
https://practicaldermatology.com/topics/practice-management/five-strategies-to-make-the-most-of-prejuvenation-minded-dermatology/20042/Congratulations! You, as a practice, were experts in “prejuvenation” well before it was a buzzy term. It is one thing to have a menu of "prevention" and "rejuvenation" oriented services and expertise. It is quite another way to market those services and skills to satisfy the next-generation patient’Optimizing Injectable Results
https://practicaldermatology.com/conferences/asds-2021/optimizing-injectable-results/20021/When it comes to injectables and facial rejuvenation, a panfacial approach can lead to optimal results. But not all patients have the budget for that. Sabrina Fabi, MD shares tips for optimizing results with a low-volume/high-yield treatment plan.A Resurgence: Ablative Resurfacing
https://practicaldermatology.com/conferences/aad-summer-2021/a-resurgence-ablative-resurfacing/19977/Mask mandates, social distancing, and increased tolerance for downtime seem to have led to an uptick in ablative resurfacing. These procedures can offer dramatic results, but Arisa Ortiz, MD says it's important to select the right patients. Plus, she offers tips for post-care counseling to manage paHair Care Trends and Treatment Advances
https://practicaldermatology.com/conferences/aad-summer-2021/hair-care-trends-and-treatment-advances/19970/Ronda S. Farah, MD shares highlights from the session she and co-panelists presented on technological advancements in the management of scalp disease. They cover the role of artificial intelligence in monitoring patients, hair cosmetic trends, lasers and platelet rich plasma in 2021, novel technologDermWireTV: Galderma Gets Cheeky, COVID Vax & Skin, AKN Classification
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-galderma-gets-cheeky-covid-vax-skin-akn-classification/19955/Only a small percentage of patients have skin reactions to COVID-19 vaccines, but true allergic reactions must be identified. FDA approves Restylane Contour from Galderma. New classification may aid treatment selection or acne keloidalis.Coding for SRT: An Update
https://practicaldermatology.com/topics/skin-cancer-photoprotection/coding-for-srt-an-update/19908/Superficial radiation therapy (SRT) is an important option for many patients with skin cancers. Find out what new changes to coding and reimbursement mean for providers and discover how SRT can fit into today's practice.Assessing the Role of Phototherapy in Psoriasis
https://practicaldermatology.com/topics/psoriasis/assessing-the-role-of-phototherapy-in-psoriasis/19887/Despite therapeutic advancements, phototherapy remains a beneficial treatment for many psoriasis patients. Henry Lim, MD summarizes his presentation from San Diego Dermatology Symposium, emphasizing safety and COVID-19 protocols.DermWireTV: AIRE SkinStore, Telehealth Cuts Consult Wait Times, Social Media and Realistic Expectations
https://practicaldermatology.com/topics/practice-management/dermwiretv-aire-skinstore-telehealth-cuts-consult-wait-times-social-media-and-realistic-expectations/19874/Launching with seven skincare brands, AIRE SkinStore allows dermatologists across the country to curate product recommendations, while providing discounts for their patients, says creator Dhaval Bhanusali, MD. Use of store-and-forward telemedicine can cut wait times for dermatology consults from 84Psoriasis Update: Understanding the Latest Psoriasis Guidelines
https://practicaldermatology.com/topics/psoriasis/psoriasis-update-understanding-the-latest-psoriasis-guidelines/19777/In a major reversal, the latest psoriasis guidelines recommend against yearly tuberculosis testing for psoriasis patients on biologics who are at low or no risk for TB, says Jashin J. Wu, MD. He also sheds light on studies comparing the 11 biologics that are currently approved for the treatment of p